miR-۳۷۵ as a key regulator of insulin secretion and diabetes progression

سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 226

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

ZISTCONF05_087

تاریخ نمایه سازی: 13 مرداد 1404

چکیده مقاله:

miR-۳۷۵ is a small RNA that is highly expressed relatively specifically in pancreatic beta cells. This microRNA is essential for normal pancreatic development and affects the number of beta and alpha cells. This RNA plays a key role in glucose-regulated insulin secretion, which it accomplishes by regulating the genes Mtpn and Pdk۱. In addition, miR-۳۷۵ affects genes related to pancreatic development and insulin secretion, making it a potential target for diabetes treatment. This review aims to gather evidence on how miR-۳۷۵ regulates insulin secretion and diabetes progression due to its significant role in diabetes. This review focuses on the role miR-۳۷۵ in beta cell function, including its effects on development and differentiation, proliferation, and regulation of insulin secretion. According to the data of the studies, the change of miR-۳۷۵ expression is likely to play a significant role in the onset and progression of diabetes. It also discusses the regulation of miR-۳۷۵ expression, miR-۳۷۵ as a potential circulating biomarker in type ۱ and type ۲ diabetes, and the need for beta cells to maintain miR-۳۷۵ expression at optimal levels. Therefore, miR-۳۷۵ can be used as a biomarker for early diagnosis of diabetes and as a therapeutic target. Despite all the evidence, further prospective studies are still needed to validate the clinical application of this microRNA.

کلیدواژه ها:

نویسندگان

Leila Abkhooie

Assistant Professor, Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.

Hadis Rahimi

Student research committee, Lorestan University of Medical Sciences, Khorramabad, Iran.

Hamed Esmaeil Lashgarian

Associate Professor, Department of Medical Genetics and Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.

Masumeh Jalalvand

Assistant Professor of Medical Biotechnology, School of Paramedicine, Bushehr University of Medical Sciences, Bushehr, Iran.

Sedigheh Momenzadeh

Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.

Sima olfati

Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.